Plant Comparison
Catnip vs Common coltsfoot
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Catnip and Common coltsfoot: they share 4 indicated uses (arthritis / joint pain, inflammation (general), insomnia / sleeplessness, …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Catnip | Common coltsfoot | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 2/10 | Comparable evidence |
| Insomnia / sleeplessness | 1/10 | 1/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The characteristic volatile iridoid responsible for the cat-attractant effect and studied for sedative, antimicrobial and insect-repellent activity.
Rich in nepetalactone isomers along with other monoterpenes; studied for antimicrobial and antioxidant activity.
Hepatotoxic constituents that are the central safety concern for this plant; regulatory limits and PA-controlled/PA-reduced products exist specifically because of these compounds.
Demulcent polysaccharide contributing to the traditional soothing action on irritated airways.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from digestive action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from sedative action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from sedative action
Safety, Cautions & Contraindications
Pregnancy: Do not use (traditional concern around stimulating menstruation/uterus) (Health Canada, n.d.). Breastfeeding: Health Canada advises talk to a healthcare professional first (Health Canada, n.d.). Kids: It’s often described as a “gentle” traditional tea, but large amounts are not a good idea—there’s a published case where a toddler became very sleepy/“slowed down” after consuming a lot. Keep catnip tea away from toddlers unless a clinician advises it (Osterhoudt et al., 1997). Sedatives / alcohol: Catnip can be calming, so don’t stack it with other sedating herbs/sleep meds/alcohol (you could get extra drowsy) (WebMD, n.d.a). Essential oil caution: Catnip essential oil is concentrated. Research notes it may cause mild skin irritation for some people—always dilute, patch test, and never treat it like “tea.” (Reichert et al., 2019)
Duke (2002) describes catnip primarily as a sedative, diaphoretic, and emmenagogue with experimental (score 1) support. It has demonstrated uterotonic and oxytocic activity, making it contraindicated in pregnancy. The active compounds include nepetalactone and iridoids. Catnip is classified as a mild nervine and antispasmodic in traditional North American herbal medicine, though clinical trials are lacking. Due to its emmenagogue and uterotonic properties, medicinal-dose use should be avoided during pregnancy (Duke, 2002).
Safety notes (contraindications, interactions, pregnancy/lactation notes, adverse effects, dose-duration cautions) Important: Coltsfoot naturally contains pyrrolizidine alkaloids (PAs)—plant chemicals that can damage the liver and may increase cancer risk with enough exposure (EMA, 2021; Kopp et al., 2020).
Because of this, European regulators set very strict limits for PA exposure from herbal products (EMA, 2021).
Many safety-focused herbal references recommend avoiding homemade/internal coltsfoot use, unless the product is specifically made to be PA-controlled / PA-reduced (EMA, 2021).
Avoid internal use if you are pregnant or breastfeeding, have liver disease, or for children—these groups are treated as “sensitive” in PA risk guidance (EMA, 2021).
Medication caution: if you take medicines that stress the liver (some prescription drugs can), it’s extra important to avoid unregulated PA exposure (general PA risk logic; consult a clinician) (EMA, 2021).
Topical use may still carry PA considerations; EMA discusses limits and recommends use only on intact skin for PA-containing products (EMA, 2021).
Duke (2002) provides clinical support (score 2) for coltsfoot's anti-inflammatory and expectorant effects, explaining its traditional use in bronchitis and coughs. However, the plant contains hepatotoxic pyrrolizidine alkaloids (PAs), and Duke notes a carcinogenic score (1) — a critical safety concern. Commission E has placed restrictions on coltsfoot use, recommending maximum internal use of 4–6 weeks per year and avoiding use in pregnancy, lactation, and in children under 12. Duke rates its overall safety as low (+) and emphasizes that preparations free of PAs are preferred (Duke, 2002).
External Ids
Botanical Description
Perennial herb, 30-100 cm tall, with greyish-green, downy, square stems typical of the mint family. Leaves are opposite, triangular-ovate with scalloped or toothed margins, grey-green above and softly felted (whitish) beneath, releasing a minty-lemony aroma when crushed. Small white flowers, spotted with purple or pink, are borne in dense terminal and axillary spikes. Nepetalactone, the volatile compound famous for its effect on cats, is concentrated in glandular hairs on the leaves and stems.[9]
Low perennial herb notable for flowering before its leaves appear: solitary, bright yellow, dandelion-like flower heads emerge on scaly pinkish stalks in very early spring, followed later by large, hoof-shaped (heart-shaped with angular teeth), white-woolly-backed leaves arising directly from the creeping rhizome.[11]
Habitat
Native to Europe and temperate Asia and widely naturalised in North America; grows on disturbed, sunny ground - roadsides, waste places, hedgebanks and dry, calcareous or well-drained soils.[9]
Grows on disturbed, damp or clay-rich waste ground, riverbanks, railway embankments and bare soil; native to Europe, North Africa and temperate Asia and naturalised in North America.[11]
Harvesting
Flowers are gathered in very early spring before the leaves appear; leaves are gathered later in the season once expanded. Given the plant's pyrrolizidine alkaloid content, harvesting from a positively confirmed patch (not a look-alike) and preferring PA-tested commercial material for internal use is strongly advised.[2]
Traditional Uses
Catnip has a long North American and European folk-medicine history as a mild sedative/nervine, diaphoretic (fever-reducing, sweat-promoting) remedy, carminative digestive and traditional emmenagogue; it was also given as a children's tea for colic and restlessness, though large amounts are not advised for young children and it is traditionally avoided in pregnancy.[9]
Coltsfoot has an ancient European and Chinese tradition, reflected in its Latin name (tussis = cough), as an expectorant and demulcent remedy for coughs, bronchitis and irritated airways; because of its pyrrolizidine alkaloid content, contemporary use is restricted to short courses of PA-controlled preparations under regulatory limits (see contraindications).[1, 2, 12]
Preparations
Commercially prepared, pyrrolizidine-alkaloid-tested extract or syrup, the only form recommended for internal use given the plant's natural PA content.
Dried flower or leaf infused in hot water; traditional but subject to strict duration/PA-content limits under EU herbal regulation.
Dosage
Health Canada's NNHPD monograph gives 1.2-12 g of dried herb top per day for adults 18 years and older, with infusion among the accepted methods of preparation. Educational reference only, not a prescription. Keep away from toddlers and young children beyond very small amounts, and avoid medicinal-dose use in pregnancy.
EU regulatory guidance restricts internal use to PA-controlled preparations. The EMA public statement on unsaturated pyrrolizidine alkaloids records a maximum daily intake for internal use of 1 microgram of PAs for at most 6 weeks per year, or 0.1 microgram per day with no duration limit; for cutaneous use the limits are 100 micrograms for at most 6 weeks per year, or 10 micrograms without a duration limit. Not for use in pregnancy, breastfeeding, or children. Note that these are limits on PA intake, not a herb dose — no EMA monograph exists for Tussilago farfara, so there is no official posology for the herb itself. Educational reference only, not a prescription — consult a qualified practitioner and prefer tested commercial products.
References
Drug Class Interactions
Not documented
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Geissler, M., Neubauer, C., Sheludko, Y.V. and Warzecha, H (2024) 'Nepeta cataria L. (catnip) can serve as a chassis for the engineering of secondary metabolic pathways', Biotechnology Letters, 46(5), pp. 843-850. doi:10.1007/s10529-024-03489-w Preclinical
https://doi.org/10.1007/s10529-024-03489-w - Lockhart, A., Simon, J.E. and Wu, Q (2024) 'Stability study of Nepeta cataria iridoids analyzed by LC/MS', Phytochemical Analysis, 35(7), pp. 1674-1687. doi:10.1002/pca.3410 Preclinical
https://doi.org/10.1002/pca.3410 - Nadeem, A., Shahzad, H., Ahmed, B., Muntean, T. and others (2022) 'Phytochemical profiling of antimicrobial and potential antioxidant plant: Nepeta cataria', Frontiers in Plant Science, 13, pp. 969316. doi:10.3389/fpls.2022.969316 Preclinical
https://doi.org/10.3389/fpls.2022.969316 - Tan, J., Li, J., Ma, J. and Qiao, F (2019) 'Hepatoprotective effect of essential oils of Nepeta cataria L. on acetaminophen-induced liver dysfunction', Bioscience Reports, 39(8), pp. BSR20190697. doi:10.1042/BSR20190697 Preclinical
https://doi.org/10.1042/BSR20190697 - Mollova, S., Dzhurmanski, A., Fidan, H., Bojilov, D. and others (2023) 'Chemical Composition of Essential Oils from Nepeta cataria L. Cultivated in Bulgaria and Their Antimicrobial and Antioxidant Activity', ACS Omega, 8(17), pp. 15441-15449. doi:10.1021/acsomega.3c00704 Preclinical
https://doi.org/10.1021/acsomega.3c00704 - Reichert, W., Ejercito, J., Guda, T., Dong, X. and others (2019) 'Repellency Assessment of Nepeta cataria Essential Oils and Isolated Nepetalactones on Aedes aegypti', Scientific Reports, 9(1), pp. 1524. doi:10.1038/s41598-018-36814-1 Preclinical
https://doi.org/10.1038/s41598-018-36814-1 - Tiwari, G., Chaturvedi, T., Gupta, A.K., Lal, R.K. and others (2023) 'Assessment of Genetic Diversity, Micromorphology and Antimicrobial Activity in Nepeta cataria L', Chemistry & Biodiversity, 20(2), pp. e202200241. doi:10.1002/cbdv.202200241 Preclinical
https://doi.org/10.1002/cbdv.202200241 - Giarratana, F., Muscolino, D., Ziino, G., Lo Presti, V. and others (2017) 'Activity of Catmint (Nepeta cataria) essential oil against Anisakis larvae', Tropical Biomedicine, 34(1), pp. 22-31. Available at: https://pubmed.ncbi.nlm.nih.gov/33592976/ Preclinical
https://pubmed.ncbi.nlm.nih.gov/33592976/ - Sarkar, M., Rashmi, R., Vikramaditya and Varma, P.N (1995) 'Pharmacognosy of Nepeta cataria', Ancient Science of Life, 14(4), pp. 225-234. Available at: https://pubmed.ncbi.nlm.nih.gov/22556702/ Traditional / reference
https://pubmed.ncbi.nlm.nih.gov/22556702/ - Bernardi, M.M., Kirsten, T.B., Lago, J.H.G., Giovani, T.M. and Massoco, C.O (2011) 'Nepeta cataria L. var. citriodora (Becker) increases penile erection in rats', Journal of Ethnopharmacology, 137(3), pp. 1318-1322. doi:10.1016/j.jep.2011.07.061 Preclinical
https://doi.org/10.1016/j.jep.2011.07.061 - Health Canada, Natural and Non-prescription Health Products Directorate (2026) 'Natural Health Product Monograph: Catnip - Nepeta cataria'. Available at: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/mono_catnip_english.pdf Traditional / reference
https://webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/mono_catnip_english.pdf - British Herbal Medicine Association (1983) 'British Herbal Pharmacopoeia'. Traditional / reference
https://scholar.google.com/scholar?q=British%20Herbal%20Pharmacopoeia - Gilani, A.H., Shah, A.J., Zubair, A., Khalid, S., Kiani, J., Ahmed, A., Rasheed, M. and Ahmad, V.U (2009) 'Chemical composition and mechanisms underlying the spasmolytic and bronchodilatory properties of the essential oil of Nepeta cataria L', 121(3), pp. 405--411. doi:10.1016/j.jep.2008.11.004 Traditional / reference
https://doi.org/10.1016/j.jep.2008.11.004 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003
- Ahmad, I., Kudaibergenova, B., Ahmad, M. and others (2025) 'Coltsfoot (Tussilago farfara L.; Asteraceae): modern methods of extraction, phytochemistry, nanoparticles synthesis, ethnopharmacology, and biological activities', Natural Product Research, pp. 1-20. doi:10.1080/14786419.2025.2548616 Traditional / reference
https://doi.org/10.1080/14786419.2025.2548616 - Chen, S., Dong, L., Quan, H., Zhou, X. and others (2020) 'A review of the ethnobotanical value, phytochemistry, pharmacology, toxicity and quality control of Tussilago farfara L. (coltsfoot)', Journal of Ethnopharmacology, 267, pp. 113478. doi:10.1016/j.jep.2020.113478 Traditional / reference
https://doi.org/10.1016/j.jep.2020.113478 - Feng, J., Zhang, Y., Qin, X., Gao, T. and others (2022) 'Novel Quinic Acid Glycerates from Tussilago farfara Inhibit Polypeptide GalNAc-Transferase', ChemBioChem, 23(3), pp. e202100539. doi:10.1002/cbic.202100539 Preclinical
https://doi.org/10.1002/cbic.202100539 - Zhao, J., Evangelopoulos, D., Bhakta, S., Gray, A.I. and Seidel, V (2014) 'Antitubercular activity of Arctium lappa and Tussilago farfara extracts and constituents', Journal of Ethnopharmacology, 155(1), pp. 796-800. doi:10.1016/j.jep.2014.06.034 Preclinical
https://doi.org/10.1016/j.jep.2014.06.034 - Avila, C., Breakspear, I., Hawrelak, J., Salmond, S. and Evans, S (2020) 'A systematic review and quality assessment of case reports of adverse events for borage (Borago officinalis), coltsfoot (Tussilago farfara) and comfrey (Symphytum officinale)', Fitoterapia, 142, pp. 104519. doi:10.1016/j.fitote.2020.104519 Meta-analysis / review
https://doi.org/10.1016/j.fitote.2020.104519 - Lee, J., Park, S., Kim, M.J., Kwon, S.J. and others (2019) 'Sesquiterpenoids from Tussilago farfara Flower Bud Extract for the Eco-Friendly Synthesis of Silver and Gold Nanoparticles Possessing Antibacterial and Anticancer Activities', Nanomaterials (Basel), 9(6), pp. 819. doi:10.3390/nano9060819 Preclinical
https://doi.org/10.3390/nano9060819 - Bota, V.B., Neamtu, A.A., Olah, N.K., Chiselita, O. and others (2022) 'A Comparative Analysis of the Anatomy, Phenolic Profile, and Antioxidant Capacity of Tussilago farfara L. Vegetative Organs', Plants (Basel), 11(13), pp. 1663. doi:10.3390/plants11131663 Preclinical
https://doi.org/10.3390/plants11131663 - Boucher, M.A., Cote, H., Pichette, A., Ripoll, L. and Legault, J (2020) 'Chemical composition and antibacterial activity of Tussilago farfara (L.) essential oil from Quebec, Canada', Natural Product Research, 34(4), pp. 545-548. doi:10.1080/14786419.2018.1489384 Preclinical
https://doi.org/10.1080/14786419.2018.1489384 - Li, Z.Y., Zhang, J., Zhang, Y.B., Yang, X.W. and others (2022) 'Polyhydroxylated eudesmane sesquiterpenoids and sesquiterpenoid glucoside from the flower buds of Tussilago farfara', Chinese Journal of Natural Medicines, 20(4), pp. 301-308. doi:10.1016/S1875-5364(21)60120-6 Preclinical
https://doi.org/10.1016/S1875-5364(21)60120-6 - Jang, H., Lee, J.W., Lee, C., Jin, Q. and others (2016) 'Sesquiterpenoids from Tussilago farfara inhibit LPS-induced nitric oxide production in macrophage RAW 264.7 cells', Archives of Pharmacal Research, 39(1), pp. 127-132. doi:10.1007/s12272-015-0667-7 Preclinical
https://doi.org/10.1007/s12272-015-0667-7 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Westendorf, J., Czok, G., Marquardt, R., Nausner, M., Krauer, B. and Paul, H.L (1988) 'Pyrrolizidine alkaloid content of Tussilago farfara plants from different regions and preparations', pp. 903--909. Traditional / reference
https://scholar.google.com/scholar?q=Pyrrolizidine%20alkaloid%20content%20of%20Tussilago%20farfara%20plants%20from%20different%20regions%20and%20preparations - European Medicines Agency (HMPC) (2021) 'Public statement on the use of herbal medicinal products containing toxic, unsaturated pyrrolizidine alkaloids (PAs), including recommendations regarding contamination of herbal medicinal products with PAs, Revision 1'. Available at: https://www.ema.europa.eu/en/documents/public-statement/public-statement-use-herbal-medicinal-products-containing-toxic-unsaturated-pyrrolizidine-alkaloids-pas-including-recommendations-regarding-contamination-herbal-medicinal-products-pyrrolizidine_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/public-statement/public-statement-use-herbal-medicinal-products-containing-toxic-unsaturated-pyrrolizidine-alkaloids-pas-including-recommendations-regarding-contamination-herbal-medicinal-products-pyrrolizidine_en.pdf - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Sperl, W. and Stuppner, H. and Gassner, I. and Judmaier, W. and Dietze, O. and Vogel, W (1995) 'Reversible hepatic veno-occlusive disease in an infant after consumption of pyrrolizidine-containing herbal tea', European Journal of Pediatrics, 154(2), pp. 112-6. doi:10.1007/BF01991912 Clinical study
https://doi.org/10.1007/BF01991912
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.